ANI Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
AbbVie USD 5.52B 1.73B 2024-12
ANI Pharmaceuticals USD 144.86M 121K 2024-12
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Canopy Growth CAD 16.31M 69.8M 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
Hikma Pharmaceutical USD 0 1000K 2024-06
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Novartis USD 11.46B 2.15B 2024-12
Perrigo USD 558.8M 904.7M 2024-12
Sun Pharmaceuticals INR 80.13B 12.73B 2024-09
Teva Pharmaceutical Industries USD 3.3B 19M 2024-12



ANI Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.